Iclusig Ponatinib 45 Mg Tablet

Link Copied
Business Type Exporter, Supplier, Distributor, Importer
Type Tablet
Quantity A+
Strength 45 Mg
Click to view more

Product Details

Brand
Iclusig 45 Mg
Material
ponatinib 45 mg
Payment Terms
T/T, Western Union

Iclusig Ponatinib is used to treat certain types of blood cancer (chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL).Iclusig is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy (1).This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with Iclusig

Yes! I am interested

Looking for "Iclusig Ponatinib 45 Mg Tablet" ?

Box

Explore More Products



Close

Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us